DRD2 and schizophrenia: Antipsychotics, acting mainly albeit not exclusively through the occupancy of dopamine D2 receptor (D2R), represent the cornerstone of schizophrenia pharmacological treatment and have proven highly effective in managing positive symptoms while being limitedly efficacious on negative and cognitive ones.